
Aurobindo Pharma Investor Relations Material
Latest events

Q3 24/25
Aurobindo Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aurobindo Pharma Limited
Access all reports
Aurobindo Pharma Limited is an Indian pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of generic medicines. The company’s product portfolio includes antibiotics, antiretrovirals, cardiovascular drugs, central nervous system agents, gastroenterology products, and anti-allergics, among others. Aurobindo Pharma serves markets globally, supplying generic pharmaceuticals to hospitals, pharmacies, and healthcare providers. The company also produces active pharmaceutical ingredients (APIs) and has expanded into specialty drugs and biosimilars. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Key slides for Aurobindo Pharma Limited


Q3 24/25
Aurobindo Pharma Limited


Q3 24/25
Aurobindo Pharma Limited
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
AUROPHARMA
Country
🇮🇳 India